Quick Takeaways
- Ezra M. Friedberg filed SCHEDULE 13D/A for Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (CHRO).
- Disclosed ownership: 8.3%.
- Date of event: 01 Jul 2025.
Ezra M. Friedberg - 01 Jul 2025 SCHEDULE 13D/A Report for Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (CHRO)
- Filing Manager
- Ezra M. Friedberg
- Reporting Manager
- Ezra Friedberg
- Symbol
- CHRO
- Shares outstanding
- 3,013,506 shares
- Disclosed Ownership
- 250,121 shares
- Ownership
- 8.3%
- Form type
- SCHEDULE 13D/A
- Filing time
- 03 Jul 2025, 21:07:22 UTC
- Date of event
- 01 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Ezra M. Friedberg disclosed 8.3% ownership in Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (CHRO) on 01 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Jul 2025, 21:07.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ezra Friedberg | 8.3% | 250,121 | 118,049 | 132,072 | /s/ Ezra Friedberg | Ezra Friedberg | 0001679440 |
| Balmoral Financial Group LLC | 3.1% | 92,072 | 0 | 92,072 | /s/ Ezra Friedberg | Ezra Friedberg | 0001988769 |
| Key Recovery Group LLC | 1.3% | 40,000 | 0 | 40,000 | /s/ Ezra Friedberg | Ezra Friedberg, Manager |